Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Lysis mediated by T cells and restricted by H-2 antigen of target cells infected with vaccinia virus

Abstract

VARIOUS virus infections lead to the formation of cytotoxic lymphocytes (CL), which are capable of killing virus-infected target cells1–4. Specific lysis of target cells infected with 51Cr-labelled vaccinia virus could be observed when investigating the cell-mediated cytotoxic reaction to vaccinia virus5; the CL could be characterised as a T cell. The sensitised lymphocytes from C3H mice could only kill syngeneic L929 cells infected with vaccinia virus, whereas lysis by sensitised lymphocytes derived from DBA/2 mice was restricted to the syngeneic infected mastocytoma P815X2 cells. In the lymphocytic choriomeningitis infection the target cell lysis was shown to be restricted by H-2 antigen6. We report here experiments with primary fibroblasts of the mouse strains C3H, DBA/2 and the (C3H × DBA/2)F1 generation were designed to affirm that the effector phase of virus-specific lysis of target cells mediated by T cells is restricted by H-2 antigen even in the vaccinia virus infection. Further experiments with H-2 alloantisera were performed to indicate the close local relationship between H-2 antigens and viral surface antigens.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Speel, L. F., Osborn, J. E., and Walker, D. L., J. Immun., 101, 409–417 (1968).

    PubMed  CAS  Google Scholar 

  2. Marker, O., and Volkert, M., J. exp. Med., 137, 1511–1525 (1973).

    Article  CAS  Google Scholar 

  3. McFarland, H. R., J. Immun., 113, 173–180 (1974).

    PubMed  CAS  Google Scholar 

  4. Gardner, I., Bowern, N. A., and Blanden, R. V., Eur. J. Immun., 4, 68–72 (1974).

    Article  CAS  Google Scholar 

  5. Koszinowski, U., and Thomssen, R., Eur. J. Immun, (in the press).

  6. Zinkernagel, R. M., and Doherty, P. C., Nature, 248, 701–702 (1974).

    Article  ADS  CAS  Google Scholar 

  7. Zinkernagel, R. M., Nature, 251, 230–231 (1974).

    Article  ADS  CAS  Google Scholar 

  8. Shearer, G. M., Eur. J. Immun., 4, 527–533 (1974).

    Article  CAS  Google Scholar 

  9. Zinkernagel, R. M., and Doherty, P. C., Nature, 251, 547–548 (1974).

    Article  ADS  CAS  Google Scholar 

  10. Schlesinger, M., and Chaouat, M., Eur. J. Immun., 5, 27–32 (1975).

    Article  CAS  Google Scholar 

  11. Hämmerling, G. J., and McDevitt, H. O., J. Immun., 112, 1634–1740 (1974).

    Google Scholar 

  12. Nabholz, M., et al., Eur. J. Immun., 4, 378–387 (1974).

    Article  CAS  Google Scholar 

  13. Blanden, R. V., et al., Nature, 254, 269–270 (1975).

    Article  ADS  CAS  Google Scholar 

  14. Snell, G. D., Catalogue of Mouse Alloantisera, Transplantation Immunology Branch Publication, (NIAID, NIH, Bethesda, Maryland, 1968 and 1974 supplement).

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

KOSZINOWSKI, U., ERTL, H. Lysis mediated by T cells and restricted by H-2 antigen of target cells infected with vaccinia virus. Nature 255, 552–554 (1975). https://doi.org/10.1038/255552a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/255552a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing